BRING-UP Prevention
The aim of this observational study is to assess in patients with a documented athero-thrombotic event: coronary artery disease (CAD), cerebrovascular disease (CVD), peripheral artery disease (PAD): * the level of adherence to guideline recommendations with the assumption to improve the rate of patients at goal for cho
| Condition(s) | Ischemic Heart Disease, Cerebrovascular Disorders, Peripheral Arterial Disease |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The aim of this observational study is to assess in patients with a documented athero-thrombotic event: coronary artery disease (CAD), cerebrovascular disease (CVD), peripheral artery disease (PAD): * the level of adherence to guideline recommendations with the assumption to improve the rate of patients at goal for cholesterol levels. * the level of adherence to guideline recommendations and the rate of patients at goal for the other relevant and modifiable risk factors for cardiovascular event recurrence. |
| Who can participate | Inclusion Criteria: * Both sexes at birth, age ≥18 years At least one of the following clinical conditions: * Documented CAD defined as: * Prior Acute Coronary Syndrom (ACS) * Prior Coronary Artery Bypass Graft (CABG) * Prior Percutaneous Coronary Intervention (PCI) * Documented PAD (previous peripheral bypass surgery or angioplasty, limb or foot amputation, intermittent claudication with objective evidence of peripheral artery disease, Ankle Brachial Index (ABI)\<90). * Documented CVD: Ischemic stroke, previous carotid vascular interventions. * Signed informed consent. Exclusion Criteria: * Active neoplasia or very severe disease compromising short-medium term life expectancy. * Participation in interventional studies. * Patients already enrolled into the study from another participating |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Heart Care Foundation |
| Locations | Canicattì, AG, Italy; Licata, AG, Italy; Casale Monferrato, AL, Italy; Novi Ligure, AL, Italy; Ancona, AN, Italy; Ancona, AN, Italy (+190 more sites) |
| Start date | 2023-09-15 |
| NCT ID | NCT06275113 |
| Official listing | https://clinicaltrials.gov/study/NCT06275113 |